Contact

Connect us

BioSyngen is developing multiple T-cell immunotherapies with the aim to address a wide range of malignancies.

SINGAPORE HEADQUATERS

Taiseng Exchange
Avenue

Taiseng Exchange, 5 Tai Seng Avenue, #08-51/52/53/54 ,
Tower C, Singapore 536671

GUANGZHOU, CHINA

1-3F., Block B, Building 6, Chuangyan Street, Sino-Singapore Knowledge City, Huangpu District, Guangzhou, P. R. China

WRITE TO US